Delivery Order SPE2DB24D2010-SPE2DB25FZYB2
Award Date
4/25/25
Potential Completion Date
5/16/25
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ibrance 125 mg capsules. The contract has a ceiling value of $8,061.38 and a completion date of February 18, 2025. It is a firm-fixed-price contract and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product, with a ceiling value of $8,067.35 and a period of performance through February 28, 2025. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,122.48, is for the supply of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 21, 2025. This contract is not associated with a set-aside program. Amerisourcebergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ibrance 125 mg capsules, a specialty medication, valued at $7,484.74. The contract has an ultimate completion date of December 5, 2023 and is structured as a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,118.08 firm fixed-price contract is for the delivery of the prescription medication Ibrance (palbociclib) 125 mg capsules. The contract has a period of performance through May 14, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of the drug IBRANCE 125 MG CAPSULE 21S. The contract has a ceiling value of $8,061.38 and runs through January 17, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for $7,796.30 and has a period of performance through March 28, 2024. It is a firm fixed-price contract for the supply of Ibrance 100 mg capsules, a specialty medication. The contract is not designated as a set-aside and appears to be an open competition award. AmerisourceBergen holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,796.30, is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product, with a period of performance through March 26, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,796.30 contract is for the supply of IBRANCE 100 MG CAPSULE 21S, a specialty cancer medication. The award has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for providing a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IBRANCE 125 MG CAPSULE 21S. The order, with a ceiling value of $7,792.08, is a firm fixed-price contract that will run through November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for...